220 related articles for article (PubMed ID: 38002085)
1. An Exploration of the Inhibitory Mechanism of Rationally Screened Benzofuran-1,3,4-Oxadiazoles and-1,2,4-Triazoles as Inhibitors of NS5B RdRp Hepatitis C Virus through Pharmacoinformatic Approaches.
Irfan A; Faisal S; Ahmad S; Saif MJ; Zahoor AF; Khan SG; Javid J; Al-Hussain SA; Muhammed MT; Zaki MEA
Biomedicines; 2023 Nov; 11(11):. PubMed ID: 38002085
[TBL] [Abstract][Full Text] [Related]
2. In Silico Development of Novel Benzofuran-1,3,4-Oxadiazoles as Lead Inhibitors of
Irfan A; Faisal S; Zahoor AF; Noreen R; Al-Hussain SA; Tuzun B; Javaid R; Elhenawy AA; Zaki MEA; Ahmad S; Abdellattif MH
Pharmaceuticals (Basel); 2023 Jun; 16(6):. PubMed ID: 37375776
[TBL] [Abstract][Full Text] [Related]
3. Repositioning of RdRp Inhibitors Against HCV NS5B Polymerase Utilizing Structure-Based Molecular Docking.
Tarannum H; Nandi S
Comb Chem High Throughput Screen; 2022; 25(4):702-719. PubMed ID: 33475069
[TBL] [Abstract][Full Text] [Related]
4. Structure-Based Virtual Screening of Furan-1,3,4-Oxadiazole Tethered
Irfan A; Faisal S; Ahmad S; Al-Hussain SA; Javed S; Zahoor AF; Parveen B; Zaki MEA
Pharmaceuticals (Basel); 2023 Feb; 16(3):. PubMed ID: 36986444
[TBL] [Abstract][Full Text] [Related]
5. BTEAC Catalyzed Ultrasonic-Assisted Synthesis of Bromobenzofuran-Oxadiazoles: Unravelling Anti-HepG-2 Cancer Therapeutic Potential through In Vitro and In Silico Studies.
Irfan A; Zahoor AF; Rasul A; Al-Hussain SA; Faisal S; Ahmad S; Noor R; Muhammed MT; Zaki MEA
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769327
[TBL] [Abstract][Full Text] [Related]
6. Combined 3D-QSAR, molecular docking, molecular dynamics simulation, and binding free energy calculation studies on the 5-hydroxy-2H-pyridazin-3-one derivatives as HCV NS5B polymerase inhibitors.
Yu H; Fang Y; Lu X; Liu Y; Zhang H
Chem Biol Drug Des; 2014 Jan; 83(1):89-105. PubMed ID: 23941500
[TBL] [Abstract][Full Text] [Related]
7. Probing the "fingers" domain binding pocket of Hepatitis C virus NS5B RdRp and D559G resistance mutation via molecular docking, molecular dynamics simulation and binding free energy calculations.
Manjula S; Sivanandam M; Kumaradhas P
J Biomol Struct Dyn; 2019 Jun; 37(9):2440-2456. PubMed ID: 30047829
[TBL] [Abstract][Full Text] [Related]
8. Phenolic compounds of Theobroma cacao L. show potential against dengue RdRp protease enzyme inhibition by In-silico docking, DFT study, MD simulation and MMGBSA calculation.
Huq AKMM; Roney M; Dubey A; Nasir MH; Tufail A; Aluwi MFFM; Ishak WMW; Islam MR; Tajuddin SN
PLoS One; 2024; 19(3):e0299238. PubMed ID: 38483871
[TBL] [Abstract][Full Text] [Related]
9. Design, Synthesis and Biological Evaluation of Novel Heterocyclic Fluoroquinolone Citrate Conjugates as Potential Inhibitors of Topoisomerase IV: A Computational Molecular Modeling Study.
Allaka TR; Katari NK; Jonnalagadda SB; Malkhed V; Anireddy JS
Curr Drug Discov Technol; 2021; 18(6):e130921187682. PubMed ID: 33155923
[TBL] [Abstract][Full Text] [Related]
10. Investigation of the New Inhibitors by Sulfadiazine and Modified Derivatives of α-D-glucopyranoside for White Spot Syndrome Virus Disease of Shrimp by In Silico: Quantum Calculations, Molecular Docking, ADMET and Molecular Dynamics Study.
Kumer A; Chakma U; Rana MM; Chandro A; Akash S; Elseehy MM; Albogami S; El-Shehawi AM
Molecules; 2022 Jun; 27(12):. PubMed ID: 35744817
[TBL] [Abstract][Full Text] [Related]
11. Ultrasonic-Assisted Synthesis of Benzofuran Appended Oxadiazole Molecules as Tyrosinase Inhibitors: Mechanistic Approach through Enzyme Inhibition, Molecular Docking, Chemoinformatics, ADMET and Drug-Likeness Studies.
Irfan A; Zahoor AF; Kamal S; Hassan M; Kloczkowski A
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142889
[TBL] [Abstract][Full Text] [Related]
12. Exploring theophylline-1,2,4-triazole tethered
Saeed S; Shahzadi I; Zahoor AF; Al-Mutairi AA; Kamal S; Faisal S; Irfan A; Al-Hussain SA; Muhammed MT; Zaki MEA
Front Chem; 2024; 12():1372378. PubMed ID: 38645776
[TBL] [Abstract][Full Text] [Related]
13. The Inhibitory Potential of 2'-dihalo Ribonucleotides against HCV: Molecular Docking, Molecular Simulations, MM-BPSA, and DFT Studies.
Khalil A; El-Khouly AS; Elkaeed EB; Eissa IH
Molecules; 2022 Jul; 27(14):. PubMed ID: 35889402
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations.
Liu YY; Feng XY; Jia WQ; Jing Z; Xu WR; Cheng XC
Comput Biol Chem; 2019 Feb; 78():190-204. PubMed ID: 30557817
[TBL] [Abstract][Full Text] [Related]
15. In-silico identification of small molecule benzofuran-1,2,3-triazole hybrids as potential inhibitors targeting EGFR in lung cancer via ligand-based pharmacophore modeling and molecular docking studies.
Kumar S; Ali I; Abbas F; Khan N; Gupta MK; Garg M; Kumar S; Kumar D
In Silico Pharmacol; 2023; 11(1):20. PubMed ID: 37575679
[TBL] [Abstract][Full Text] [Related]
16. Potent toxic effects of Taroxaz-104 on the replication of SARS-CoV-2 particles.
Rabie AM
Chem Biol Interact; 2021 Jul; 343():109480. PubMed ID: 33887223
[TBL] [Abstract][Full Text] [Related]
17. Targeting the 3CLpro and RdRp of SARS-CoV-2 with phytochemicals from medicinal plants of the Andean Region: molecular docking and molecular dynamics simulations.
Mosquera-Yuqui F; Lopez-Guerra N; Moncayo-Palacio EA
J Biomol Struct Dyn; 2022 Mar; 40(5):2010-2023. PubMed ID: 33084512
[TBL] [Abstract][Full Text] [Related]
18. Facilitating SARS CoV-2 RNA-Dependent RNA polymerase (RdRp) drug discovery by the aid of HCV NS5B palm subdomain binders: In silico approaches and benchmarking.
Elghoneimy LK; Ismail MI; Boeckler FM; Azzazy HME; Ibrahim TM
Comput Biol Med; 2021 Jul; 134():104468. PubMed ID: 34015671
[TBL] [Abstract][Full Text] [Related]
19. Molecular modeling and residue interaction network studies on the mechanism of binding and resistance of the HCV NS5B polymerase mutants to VX-222 and ANA598.
Xue W; Jiao P; Liu H; Yao X
Antiviral Res; 2014 Apr; 104():40-51. PubMed ID: 24462692
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic potential of Taraxacum officinale against HCV NS5B polymerase: In-vitro and In silico study.
Rehman S; Ijaz B; Fatima N; Muhammad SA; Riazuddin S
Biomed Pharmacother; 2016 Oct; 83():881-891. PubMed ID: 27513212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
